# Polyunsaturated Fatty Acids in Patients With NAFLD.

> **NCT02647294** · NA · COMPLETED · sponsor: **General University Hospital, Prague** · enrollment: 60 (actual)

## Conditions studied

- NAFLD

## Interventions

- **DIETARY_SUPPLEMENT:** Maxicor
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02647294
- **Lead sponsor:** General University Hospital, Prague
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2020-06
- **Final completion:** 2020-06-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02647294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02647294, "Polyunsaturated Fatty Acids in Patients With NAFLD.". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02647294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*